Barbexaclone
Chemical compound / From Wikipedia, the free encyclopedia
Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine.[2] It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results"[3] had not yet been confirmed nor denied in controlled trials.
Quick Facts Combination of, Phenobarbital ...
Combination of | |
---|---|
Phenobarbital | Barbiturate |
Levopropylhexedrine | Sympathomimetic |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.022.278 |
NY (what is this?) (verify) |
Close